AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 249: H995-H1000, 1985;
0363-6135/85 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kainuma, M.
Right arrow Articles by Ishikawa, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kainuma, M.
Right arrow Articles by Ishikawa, N.

AJP - Heart and Circulatory Physiology, Vol 249, Issue 5 995-1000, Copyright © 1985 by American Physiological Society


ARTICLES

Coronary flow in heart-lung preparation affected by cardiopulmonary nerves and arterial PCO2

M. Kainuma, I. Ichimura, T. Shigei and N. Ishikawa

Studies on coronary vasodilator drugs utilizing heart-lung preparations (HLP) have been disturbed by a spontaneous gradual increase in coronary blood flow. With the purpose of finding out what would cause the gradual increase, the time course of coronary sinus blood flow (CSBF) was investigated in 20 dog HLPs under four experimental conditions, according to whether cardiopulmonary nerves (CPN) were severed or not and whether CO2 content in the inspiratory gas was high (95% O2-5% CO2) or low (50% O2-50% room air). The gradual increase in CSBF was observed, accompanied by a significant increase in 6-ketoprostaglandin F1 alpha in the arterial blood, only when CPN were intact and, simultaneously, inspiratory CO2 was high. Nevertheless, the hemodynamic parameters, except CSBF, were almost similar under four conditions. These results suggested that CSBF in HLP could be affected via a synthesis and/or a release of prostaglandin I2 by the interaction of CPN and arterial PCO2.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online